Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease-Reference-Cited by-同舟云学术

Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease

Published:2022-09-10 Issue:6 Volume:32 Page:1381-1394
ISSN:1976-4251
Container-title:Carbon Letters
language:en
Short-container-title:Carbon Lett.

Author:

Ghosh Shampa,Sachdeva Bhuvi,Sachdeva Punya,Chaudhary Vishal,Rani Gokana Mohana,Sinha Jitendra Kumar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Materials Chemistry,Inorganic Chemistry,Organic Chemistry,Process Chemistry and Technology,Energy Engineering and Power Technology,Renewable Energy, Sustainability and the Environment,Ceramics and Composites

Link

https://link.springer.com/content/pdf/10.1007/s42823-022-00397-9.pdf

Reference122 articles.

1. Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK (2020) Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer’s disease. Curr Neuropharmacol 18(9):883–903. https://doi.org/10.2174/1570159X18666200429011823

2. Crous-Bou M, Minguillón C, Gramunt N, Molinuevo JL (2017) Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimer’s Res Therapy 9(1):71. https://doi.org/10.1186/s13195-017-0297-z

3. Möller HJ, Graeber MB (1998) The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 248(3):111–122. https://doi.org/10.1007/s004060050027

4. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell L, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Weiner MW (2008) The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods. J Magn Resonan Imaging JMRI 27(4):685–691. https://doi.org/10.1002/jmri.21049

5. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement 7(3):280–292. https://doi.org/10.1016/j.jalz.2011.03.003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma;ASSAY and Drug Development Technologies;2024-01-09

2. Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

3. Theoretical insights into tunable electronic properties of graphene quantum dots through ZnO doping;Chemical Physics Impact;2023-12

4. Second-Order Nonlinearity of Graphene Quantum Dots Measured by Hyper-Rayleigh Scattering;Materials;2023-11-27

5. Emerging Therapeutic Targets in Molecular Neuropharmacology for Alzheimer's Disease;J BIOL REG HOMEOS AG;2023